CEO
Mark C. McKenna
Employees
72
Industry
Pharmaceutical Preparation Manufacturing
prometheus biosciences, inc., is a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases.
Loading...
Open
199.68
Mkt cap
9.6B
Volume
1.8M
High
199.96
P/E Ratio
-56.47
52-wk high
199.96
Low
199.92
Div yield
N/A
52-wk low
23.27
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.